Histology and Cytology Market (By Type Of Examination: Histology, Cytology; By Product: Instruments and Analysis Software System, Consumable and Reagents; By Application: Drug Discovery & Designing, Clinical Diagnostics, Research) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The global histology and cytology market is expected to grow at a CAGR of around 12.8% from 2020 to 2027 and expected to reach the market value of around US$ 39.8 Bn by 2027

Cytology is a branch of biology which studies detailed examination of individual cells in both plants and animals including human beings; whereas histology is the study of cell internal characteristics under the microscope. These tests are majorly done to detect and treat infectious diseases and cancer. The examination is executed by placing the sample cell or tissue under a digital or electronic microscope. Cancer is the second major cause of death after cardiovascular diseases. Early detection of cancer and risk factors would improve prevention, survival rate and quality of human being lives. According to World Health Organization, cancer is one of the leading causes of morbidity and mortality after cardiovascular diseases across the globe, accounting for around 9.5 million deaths in 2018. Huge increase in the prevalence of cancer, technological augmentations in diagnostic and molecular methods, rising standardization of pathological laboratories and favorable reimbursements for cancer screening and laboratory tests are the factors responsible for the high CAGR of the market during the forecast period. 

According to International Agency for Research, 2020 Cancer is responsible for 8.51 lakh deaths in India every year. As per World Health Organization (WHO), one in 10 Indians will develop cancer during their lifetime, and one in 15 will die of cancer. According to the American Cancer Society, an estimated 81,000 cases of bladder cancer will be diagnosed in the U.S in 2021. Accurate detection of bladder cancer, or urothelial carcinoma (UC), is often difficult and expensive, requiring invasive camera-based testing methodology. Cytology and Histology are quite popular and demand methods for diagnosing such cancers.

Market Dynamics

The surge in well-equipped diagnostic systems and favourable reimbursement for cancer screening and laboratory test is having a positive effect on market growth. The factors contributing to market growth include increasing incidence and prevalence of cancer due to lifestyle changes, development of advanced tools for early disease diagnosis, execution of immunohistochemistry, and innovation in microscopy examination. Collaboration of healthcare organizations & research institutions with the standardization of cytopathology across the world, is driving the market. The integration of digital solutions to cytology offers the advantage of the rapid interpretation of primary diagnostic data. Continuous R&D efforts and investment by industry players broaden the scope of its application in disease diagnosis. Furthermore, conducting awareness programs about cancer will boost business revenue even further. However, the high cost of diagnosis may limit the growth of the histology & cytology market in the coming years.

Segment Analysis by Region

The global histology & cytology market has been divided into five major regions: North America, Europe, APAC, LATAM, and Middle East & Africa. North America is dominating the market for the entire forecast period followed by Europe. North America region is projected to accelerate the growth of the market due to an increase in the prevalence of cancer. Technological advancements and innovation towards early detection of disease in this particular region expected to fuel the growth of the market. India and China in the APAC region are expected to have the fastest growth in the market due to the presence of a large patient pool and population in the region suffering from various infectious diseases will benefit regional growth. In the coming years, regional business growth will be accelerated by rising demand for efficient sample testing, early diagnosis and government involvement which will result in timely treatment and faster patient outcomes.

Covid-19 Impact on Global Histology and Cytology Market:

The strategic collaboration is being observed between many companies for developing antibodies specific for validation with immunohistochemistry. For instance, GeneTex, Inc., a leading research antibody manufacturer, has developed the most comprehensive and well-characterized catalogue of SARS-CoV-2 reagents for researchers. To further optimize these antibodies, GeneTex has partnered with HistoWiz, Inc., which specializes in histopathological services. The first phase of this collaboration has established several highly validated antibodies for immunohistochemistry (IHC) on human SARS-CoV-2-infected tissues.

The pandemic has become a stimulating factor for changing traditional pathology workflows with the integration of Artificial Intelligence (AI) and digitalization solutions for early diagnosis and treatment. During the pandemic, these methods have been assisted many healthcare professionals to understand the results virtually.

Competitive Landscape

Roche, BD, 3DHISTECH, Abbott Laboratories, Danaher, are the major key players in the cytology and histology market. And some other major players in the global market for histology and cytology are trying to bring automated digital imaging solutions that can enhance the rapid results Many companies are focusing on developing economies where there is huge untapped revenue potential outstanding to improved healthcare infrastructure in recent years. The top key players in the market are F.Hoffmann-La Roche, Hologic, Inc., Becton, Dickinson & Company, Merck KGaA, Danaher Corporation, Abbott Laboratories, Philips Healthcare, Sysmex Corporation, Koninklijke, and Trivitron Healthcare. Mergers and acquisitions among the top key players are key strategies to propel the market next level.

Histology and Cytology Market Segment Analysis, 2021

The Global Histology and Cytology market is segmented into Examination Type, Product Type, Application and Region. The Examination type is further subdivided into Histology and Cytology. The Test type is segregated as Instruments and Analysis Software systems. And the Application is further segmented into Hospitals, Diagnostic centers, Research institutes and others.

Market Segmentation

Market By Type Of Examination

Histology

  • Microscopy Technique
  • Immunohistochemistry Technique
  • Molecular pathology Technique
  • Cryostat & Microtomy Technique

Cytology

  • Breast Cancer
  • Cervical Cancer
  • Bladder Cancer
  • Lung Cancer
  • Other Cancers

Market By Product

Instruments and Analysis Software System
Consumable and Reagents

Market By Application

Drug Discovery & Designing
Clinical Diagnostics
Research

Market By Geography

North America
•    U.S.
•    Canada

Europe
•    U.K.
•    Germany
•    France
•    Spain
•    Rest of Europe

Asia-Pacific
•    China
•    Japan
•    India
•    Australia
•    South Korea
•    Rest of Asia-Pacific

Latin America
•    Brazil 
•    Mexico
•    Rest of Latin America

Middle East & Africa
•    GCC
•    South Africa
•    Rest of Middle East & Africa


Frequently Asked Questions

Histology and cytology market is expected to reach a market value of around US$ 39.8 Bn by 2027.

The histology and cytology market is expected to grow at a CAGR of around 12.8% from 2020 to 2027.

Based on type of examination, cytology segment is the leading segment in the overall market.

Technological advancements is one of the prominent factors that drive the demand for histology and cytology market.

F.Hoffmann-La Roche, Hologic, Inc., Becton, Dickinson & Company, Merck KGaA, Danaher Corporation, Abbott Laboratories, Philips Healthcare, Sysmex Corporation, Koninklijke, and Trivitron Healthcare

North America is anticipated to grab the highest market share in the regional market

Asia Pacific is expected to be the fastest growing market in the forthcoming years

Cart Summary


60